Lv1
60 积分 2024-04-23 加入
The oncogenic EGFR-SHC1 fusion confers insensitivity to EGFR-TKI via dual activation of N-EGFR kinase domain and C-SHC1 phosphorylation sites in lung cancer
6天前
已完结
IL-6 drives chemoimmunotherapy resistance in NSCLC by reprogramming myeloid cells and impairing cytotoxic lymphocyte function
1个月前
已完结
Activating NEDD4L suppresses EGFR-driven lung adenocarcinoma growth via facilitating EGFR proteasomal degradation
2个月前
已完结
EGFR inhibitor-resistant lung cancers exhibit collateral sensitivity to a covalent, cysteine-independent KEAP1 oligomerizing molecular bridge
3个月前
已关闭
Lymph node colonization induces tissue remodeling via immunosuppressive fibroblast-myeloid cell niches supporting metastatic tolerance
3个月前
已完结
Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group
3个月前
已完结
Tertiary lymphoid structures in anticancer immunity
3个月前
已完结
Multi-omics models for predicting prognosis in non-small cell lung cancer patients following chemotherapy and radiotherapy: A multi-center study
4个月前
已完结
Targeting senescent EGR1+ B cells enhances immunotherapy efficacy in esophageal squamous cell carcinoma
4个月前
已完结
T cell receptor therapeutics: immunological targeting of the intracellular cancer proteome
4个月前
已完结
皖公网安备34019202002308
